Alliancebernstein L.P. Catalent, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,113,219 shares of CTLT stock, worth $70.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,113,219

Previous 1,250,470 10.98%

Holding current value

$70.7 Million

Previous $70.3 Million 4.1%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $7.71 Million - $8.37 Million	-137,251 Reduced 10.98%	1,113,219 $67.4 Million
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $15.3 Million - $16.3 Million	285,410 Added 29.57%	1,250,470 $70.3 Million
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $32.2 Million - $45.3 Million	757,423 Added 364.78%	965,060 $54.5 Million
Q4 2023 Feb 14, 2024	SELL	$32.18 - $46.57 $14,513 - $21,003	-451 Reduced 0.22%	207,637 $9.33 Million
Q3 2023 Nov 14, 2023	SELL	$44.2 - $50.2 $2.03 Million - $2.31 Million	-45,927 Reduced 18.08%	208,088 $9.47 Million
Q2 2023 Aug 15, 2023	SELL	$31.86 - $67.26 $5.33 Million - $11.3 Million	-167,277 Reduced 39.71%	254,015 $11 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $8.33 Million - $13.6 Million	183,419 Added 77.11%	421,292 $27.7 Million
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $181,370 - $354,942	-4,382 Reduced 1.81%	237,873 $10.7 Million
Q3 2022 Nov 15, 2022	BUY	$72.36 - $113.1 $1.79 Million - $2.79 Million	24,703 Added 11.35%	242,255 $17.5 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $5.51 Million - $7.21 Million	-63,200 Reduced 22.51%	217,552 $23.3 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $7.58 Million - $10 Million	-80,489 Reduced 22.28%	280,752 $31.1 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $17 Million - $19.8 Million	142,273 Added 64.97%	361,241 $46.3 Million
Q3 2021 Nov 10, 2021	BUY	$109.17 - $142.35 $280,348 - $365,554	2,568 Added 1.19%	218,968 $29.1 Million
Q2 2021 Jul 30, 2021	BUY	$100.34 - $115.69 $61,207 - $70,570	610 Added 0.28%	216,400 $23.4 Million
Q1 2021 May 06, 2021	SELL	$101.51 - $125.27 $102,423 - $126,397	-1,009 Reduced 0.47%	215,790 $22.7 Million
Q4 2020 Feb 08, 2021	SELL	$85.88 - $105.36 $1.03 Million - $1.27 Million	-12,043 Reduced 5.26%	216,799 $22.6 Million
Q3 2020 Nov 12, 2020	SELL	$72.74 - $92.5 $2.79 Million - $3.55 Million	-38,336 Reduced 14.35%	228,842 $19.6 Million
Q2 2020 Aug 13, 2020	SELL	$48.02 - $79.04 $654,800 - $1.08 Million	-13,636 Reduced 4.86%	267,178 $19.6 Million
Q1 2020 May 14, 2020	BUY	$36.95 - $62.95 $302,990 - $516,190	8,200 Added 3.01%	280,814 $14.6 Million
Q4 2019 Feb 18, 2020	BUY	$47.06 - $56.64 $386,362 - $465,014	8,210 Added 3.11%	272,614 $15.3 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $4,982 - $6,095	105 Added 0.04%	264,404 $12.6 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $505,276 - $697,682	-12,870 Reduced 4.64%	264,299 $14.3 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $445,212 - $655,286	-14,920 Reduced 5.11%	277,169 $11.3 Million
Q4 2018 Feb 13, 2019	BUY	$29.95 - $46.34 $1.4 Million - $2.17 Million	46,870 Added 19.11%	292,089 $9.11 Million
Q3 2018 Nov 08, 2018	BUY	$40.12 - $45.55 $3.87 Million - $4.39 Million	96,400 Added 64.78%	245,219 $11.2 Million
Q2 2018 Aug 13, 2018	SELL	$38.72 - $42.52 $5.25 Million - $5.77 Million	-135,685 Reduced 47.69%	148,819 $6.23 Million
Q1 2018 May 14, 2018	SELL	$39.4 - $47.39 $499,198 - $600,431	-12,670 Reduced 4.26%	284,504 $11.7 Million
Q4 2017 Feb 13, 2018	BUY	$37.27 - $43.02 $1.05 Million - $1.21 Million	28,090 Added 10.44%	297,174 $12.2 Million
Q3 2017 Nov 13, 2017	BUY	$33.75 - $41.67 $9.08 Million - $11.2 Million	269,084	269,084 $10.7 Million

Others Institutions Holding CTLT

# of Institutions

514

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Catalent, Inc. Transaction History